TCF7L2 positively regulates aerobic glycolysis via the EGLN2/HIF-1α axis and indicates prognosis in pancreatic cancer
Jinfeng Xiang(AstraZeneca (Poland)), Xianjun Yu(Fudan University Shanghai Cancer Center)
Cited by 57
Related Papers
ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer
|Cell Research|2015|141
New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer
|Pancreatology|2018|79
The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients
|Pancreatology|2016|65
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours
|Neuroendocrinology|2018|55